Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$321K Buy
3,533
+807
+30% +$73.7K 0.04% 159
2026
Q1
$280K Sell
2,726
-125
-4% -$14.1K 0.03% 167
2025
Q4
$357K Sell
2,851
-13
-0.5% -$1.66K 0.04% 171
2025
Q3
$384K Sell
2,864
-132
-4% -$17.3K 0.05% 161
2025
Q2
$408K Buy
2,996
+422
+16% +$55.6K 0.06% 146
2025
Q1
$341K Buy
2,574
+207
+9% +$26.3K 0.06% 152
2024
Q4
$268K Buy
2,367
+160
+7% +$18.5K 0.05% 185
2024
Q3
$252K Buy
2,207
+28
+1% +$3.07K 0.05% 174
2024
Q2
$226K Sell
2,179
-192
-8% -$20.4K 0.05% 204
2024
Q1
$270K Buy
+2,371
New +$272K 0.06% 184

Other funds holding ABT

MJP Associates's ABT Position: Q2 2026 in Review

MJP Associates increased its Abbott (ABT) stake by 30% in Q2 2026, buying an estimated $73.7K and bringing the position to 3,533 shares worth $321K. The position accounts for 0.04% of the portfolio, ranked #159.

MJP Associates first reported a position in ABT in Q1 2024 and has held it in 10 quarters since. The position peaked at $408K in Q2 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • MJP Associates held 3,533 shares of Abbott worth $321K as of Q2 2026.
  • MJP Associates bought 807 Abbott shares in Q2 2026, an estimated $73.7K.
  • Abbott made up 0.04% of MJP Associates's portfolio in Q2 2026, its #159 holding.
  • MJP Associates first reported a position in Abbott in Q1 2024 and has held it in 10 quarters since.
  • MJP Associates's Abbott position peaked at $408K in Q2 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.